Together, our findings suggest that chemotherapy may activate immune response mechanisms such as IFNα, IFNγ, STAT3, and TNFα in lung cancer, which may generate a favorable tumor microenvironment for subsequent response to checkpoint immunotherapy. Here, STAT3 is linked to lung cancer.